Form 4: Mersana Therapeutics VP Ashish Mandelia Reports Stock Sales to Cover Tax Obligations
SEC Form 4 Filing
Ashish Mandelia, VP and Chief Accounting Officer of Mersana Therapeutics, reports the sale of common stock to cover tax obligations related to vested restricted stock units.
Summary
- On October 1, 2024, Ashish Mandelia, VP and Chief Accounting Officer of Mersana Therapeutics, vested 30,000 restricted stock units (RSUs) which converted into common stock.
- Mandelia sold 4,855 shares of common stock on October 2, 2024, at a weighted average price of $2 per share.
- An additional 3,361 shares were sold on October 3, 2024, at a weighted average price of $1.96 per share.
- These sales were executed to cover tax withholding obligations related to the vesting of the RSUs, pursuant to a pre-arranged Rule 10b5-1 trading plan.
- Following these transactions, Mandelia directly owns 47,757 shares of Mersana Therapeutics common stock.
Sentiment
Score: 5
Explanation: The document reflects routine transactions related to executive compensation and tax obligations, with no clear positive or negative implications for the company's outlook.
Industry Context
Sales of shares to cover tax obligations are a routine part of equity compensation plans, and are not necessarily indicative of the officer's sentiment towards the company's future prospects.
Key Dates
| Date | Description |
|---|---|
| May 10, 2023 | Reporting Person adopted a Rule 10b5-1 trading plan |
| September 5, 2023 | RSUs awarded to the Reporting Person |
| October 1, 2024 | Date of earliest transaction; RSUs vested and converted to common stock |
| October 2, 2024 | Sale of 4,855 shares of common stock |
| October 3, 2024 | Sale of 3,361 shares of common stock |
| October 7, 2024 | Date of Form 4 filing |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.